Compass Ion Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Compass Ion Advisors's AMGN Position: Q3 2026 in Review
Compass Ion Advisors reduced its Amgen (AMGN) stake by 0.43% in Q3 2026, selling an estimated $9.6K and leaving 5,553 shares worth $2.34M. The position accounts for 0.2% of the portfolio, ranked #60.
Compass Ion Advisors first reported a position in AMGN in Q3 2023 and has held it in 13 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Compass Ion Advisors held 5,553 shares of Amgen worth $2.34M as of Q3 2026.
- Compass Ion Advisors sold 24 Amgen shares in Q3 2026, an estimated $9.6K.
- Amgen made up 0.2% of Compass Ion Advisors's portfolio in Q3 2026, its #60 holding.
- Compass Ion Advisors first reported a position in Amgen in Q3 2023 and has held it in 13 quarters since.
- 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Compass Ion Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.